Hypomyelination and Congenital Cataract: Neuroimaging Features of a Novel Inherited White Matter Disorder

References

1. ↵
   van der Knaap MS, Breiter SN, Naidu S, et al. Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology 1999;213:121–33

   CrossRefPubMedWeb of Science
2. ↵
   Schiffmann R, van der Knaap MS. The latest on leukodystrophies. Curr Opin Neurol 2004;17:187–92

   CrossRefPubMedWeb of Science
3. ↵
   Zara F, Biancheri R, Bruno C, et al. Deficiency of hyccin, a newly identified membrane protein, causes hypomyelination and congenital cataract. Nat Genet 2006;38:1111–13. Epub 2006 Sep 3

   CrossRefPubMedWeb of Science
4. ↵
   van der Knaap MS, Naidu S, Pouwels PJ, et al. New syndrome characterized by hypomyelination with atrophy of the basal ganglia and cerebellum. AJNR Am J Neuroradiol 2002;23:1466–74

   Abstract/FREE Full Text
5. ↵
   Provencher SW. Estimation of metabolite concentrations from localized in vivo proton MR spectra. Magn Reson Med 1993;30:672–79

   CrossRefPubMedWeb of Science
6. ↵
   Di Rocco M, Rossi A, Parenti G, et al. Different molecular mechanisms leading to white matter hypomyelination in infantile onset lysosomal disorders. Neuropediatrics 2005;36:265–69

   CrossRefPubMedWeb of Science
7. ↵
   van der Knaap MS, Naidu S, Breiter SN, et al. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol 2001;22:541–52

   Abstract/FREE Full Text
8. Brismar J, Brismar G, Gascon G, et al. Canavan disease: CT and MR imaging of the brain. AJNR Am J Neuroradiol 1990;11:805–10

   Abstract/FREE Full Text
9. van der Knaap MS, Barth PG, Stroink H, et al. Leukoencephalopathy with swelling and a discrepantly mild clinical course in eight children. Ann Neurol 1995;37:324–34

   CrossRefPubMedWeb of Science
10. ↵
    van der Knaap MS, Barth PG, Gabreels FJ, et al. A new leukoencephalopathy with vanishing white matter. Neurology 1997;48:845–55

    Abstract/FREE Full Text
11. ↵
    Hanefeld FA, Brockmann K, Pouwels PJ, et al. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination. Neurology 2005;65:701–06

    Abstract/FREE Full Text
12. ↵
    Varho T, Komu M, Sonninen P, et al. A new metabolite contributing to N-acetyl signal in 1HMRS of the brain in Salla disease. Neurology 1999;52:1668–72

    Abstract/FREE Full Text
13. ↵
    Degaonkar MN, Khubchandhani M, Dhawan JK, et al.. Sequential proton MRS study of brain metabolite changes monitored during a complete pathological cycle of demyelination and remyelination in a lysophosphatidyl choline (LPC)-induced experimental demyelinating lesion model. NMR Biomed 2002;15:293–300

    CrossRefPubMed